These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
128 results:

  • 1. LINC00982-encoded protein PRDM16-DT regulates
    Hu HF; Han L; Fu JY; He X; Tan JF; Chen QP; Han JR; He QY
    Theranostics; 2024; 14(8):3317-3338. PubMed ID: 38855188
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer.
    Qin W; Li J; Gao N; Kong X; Guo L; Chen Y; Huang L; Chen X; Qi F
    Mol Cancer; 2024 May; 23(1):99. PubMed ID: 38730464
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and foxp3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PD-L1 Expression in colorectal Carcinoma Correlates with the Immune Microenvironment.
    Shahin M; Patra S; Purkait S; Kar M; Das Majumdar SK; Mishra TS; Samal SC; Nayak HK
    J Gastrointest Cancer; 2024 Jun; 55(2):940-949. PubMed ID: 38530597
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
    Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
    Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
    Edin S; Gylling B; Li X; Stenberg Å; Löfgren-Burström A; Zingmark C; van Guelpen B; Ljuslinder I; Ling A; Palmqvist R
    Br J Cancer; 2024 Jan; 130(1):143-150. PubMed ID: 38040818
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.
    Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
    World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Propolis Has an Anticancer Effect on Early Stage colorectal cancer by Affecting Epithelial Differentiation and Gut Immunity in the Tumor Microenvironment.
    Shen MH; Liu CY; Chang KW; Lai CL; Chang SC; Huang CJ
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960147
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in cancer.
    Pinioti S; Sharma H; Flerin NC; Yu Q; Tzoumpa A; Trusso Cafarello S; De Bousser E; Callewaert N; Oldenhove G; Schlenner S; Thienpont B; Garg AD; Di Matteo M; Mazzone M
    Cancer Immunol Res; 2023 Dec; 11(12):1611-1629. PubMed ID: 37933083
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immune microenvironment and lymph node yield in colorectal cancer.
    Lee SH; Pankaj A; Neyaz A; Ono Y; Rickelt S; Ferrone C; Ting D; Patil DT; Yilmaz O; Berger D; Deshpande V; Yılmaz O
    Br J Cancer; 2023 Oct; 129(6):917-924. PubMed ID: 37507544
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical, pathological, genetics and intratumoural immune milieu of micropapillary carcinoma of the colon.
    Deshpande V; Lee SH; Crabbe A; Pankaj A; Neyaz A; Ono Y; Rickelt S; Sonal S; Ferrone CR; Ting DT; Patil D; Yilmaz O; Berger D; Yilmaz O
    J Clin Pathol; 2024 May; 77(6):387-393. PubMed ID: 37258254
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Relationship Between Infiltration of CD163+ TAMs, foxp3+ Tregs, or CD66b+ TANs and Cell Differentiation in colorectal cancer Tissues.
    Wang X; Bai Y; Zhou Z; Ye B; Chen Z; Chen X; Wu W
    Turk J Gastroenterol; 2023 Jul; 34(7):747-752. PubMed ID: 37232465
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IL-6 Levels Correlate with prognosis and Immunosuppressive Stromal Cells in Patients with colorectal cancer.
    Yamamoto T; Tsunedomi R; Nakajima M; Suzuki N; Yoshida S; Tomochika S; Xu M; Nakagami Y; Matsui H; Tokumitsu Y; Shindo Y; Watanabe Y; Iida M; Takeda S; Hazama S; Tanabe T; Ioka T; Hoshii Y; Kiyota A; Takizawa H; Kawakami Y; Ueno T; Nagano H
    Ann Surg Oncol; 2023 Aug; 30(8):5267-5277. PubMed ID: 37222942
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunological and Clinico-Molecular Features of Tumor Border Configuration in colorectal cancer.
    Sonal S; Deshpande V; Ting DT; Neyaz A; Pankaj A; Taylor MS; Dinaux AM; Leijssen LG; Boudreau C; Berger DL
    J Am Coll Surg; 2023 Jan; 236(1):126-134. PubMed ID: 36519916
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2.
    Jiang M; Yang Y; Niu L; Li P; Chen Y; Liao P; Wang Y; Zheng J; Chen F; He H; Li H; Chen X
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36319063
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bile acid distributions, sex-specificity, and prognosis in colorectal cancer.
    Cai Y; Shen X; Lu L; Yan H; Huang H; Gaule P; Muca E; Theriot CM; Rattray Z; Rattray NJW; Lu J; Ahuja N; Zhang Y; Paty PB; Khan SA; Johnson CH
    Biol Sex Differ; 2022 Oct; 13(1):61. PubMed ID: 36274154
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CD4 and foxp3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule.
    Nakagami Y; Hazama S; Suzuki N; Yoshida S; Tomochika S; Matsui H; Shindo Y; Tokumitsu Y; Matsukuma S; Watanabe Y; Iida M; Tsunedomi R; Takeda S; Fujita T; Kawakami Y; Ogihara H; Hamamoto Y; Ioka T; Tanabe T; Ueno T; Nagano H
    BMC Cancer; 2022 Oct; 22(1):1071. PubMed ID: 36253752
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immune Evasion and Drug Resistance Mediated by USP22 in cancer: Novel Targets and Mechanisms.
    Guo J; Zhao J; Fu W; Xu Q; Huang D
    Front Immunol; 2022; 13():918314. PubMed ID: 35935969
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular Basis of Extramural Vascular Invasion (EMVI) in colorectal Carcinoma.
    Sonal S; Deshpande V; Ting DT; Cusack JC; Parikh AR; Neyaz A; Pankaj A; Taylor MS; Dinaux AM; Leijssen LGJ; Boudreau C; Locascio JJ; Kunitake H; Goldstone RN; Bordeianou LG; Cauley CE; Ricciardi R; Berger DL
    Ann Surg Oncol; 2022 Nov; 29(12):7372-7382. PubMed ID: 35917013
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
    Kanno H; Hisaka T; Akiba J; Hashimoto K; Fujita F; Akagi Y
    BMC Cancer; 2022 Aug; 22(1):839. PubMed ID: 35915403
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.